NasdaqCM:EXASBiotechs
Exact Sciences EHR Outreach Lifts CRC Screening And Fuels Investor Interest
Exact Sciences, Amalgam Rx and Privia Health report materially higher colorectal cancer screening rates using EHR-enabled outreach and at home noninvasive tests.
The coordinated program is described as scalable and has surpassed national screening benchmarks during Colorectal Cancer Awareness Month.
The initiative focuses on closing screening gaps by embedding screening prompts and workflows directly into clinical systems and patient communications.
For investors watching NasdaqCM:EXAS,...

